Annotations
Pathway Ontology
disease pathway (PW:0000013)
Complex human diseases encompass a spectrum of genetic and environmental attributes that together affect the normal functioning of several molecular and cellular pathways. Their combined and accumulated effect is manifested in the anomalous phenotype of the complex condition.
Table Filters
- Lipids measured in liver metastasis from breast cancer - WP4627 (Mus musculus)
- 10q11.21q11.23 copy number variation syndrome - WP5352 (Homo sapiens)
- 10q22q23 copy number variation - WP5402 (Homo sapiens)
- 11p11.2 copy number variation syndrome - WP5348 (Homo sapiens)
- 13q12 or CRYL1 copy number variation - WP5405 (Homo sapiens)
- 13q12.12 copy number variation - WP5406 (Homo sapiens)
- 15q11.2 copy number variation syndrome - WP4940 (Homo sapiens)
- 15q11q13 copy number variation - WP5407 (Homo sapiens)
- 15q13.3 copy number variation syndrome - WP4942 (Homo sapiens)
- 15q25 copy number variation - WP5408 (Homo sapiens)
- 16p11.2 distal deletion syndrome - WP4950 (Homo sapiens)
- 16p11.2 proximal deletion syndrome - WP4949 (Homo sapiens)
- 17p13.3 (YWHAE) copy number variation - WP5376 (Homo sapiens)
- 17q12 copy number variation syndrome - WP5287 (Homo sapiens)
- 1p36 copy number variation syndrome - WP5345 (Homo sapiens)
- 1q21.1 copy number variation syndrome - WP4905 (Homo sapiens)
- 22q11.2 copy number variation syndrome - WP4657 (Homo sapiens)
- 2q11.2 copy number variation syndrome - WP5221 (Homo sapiens)
- 2q13 copy number variation syndrome - WP5222 (Homo sapiens)
- 2q21.1 copy number variation syndrome - WP5223 (Homo sapiens)
- 2q37 copy number variation syndrome - WP5224 (Homo sapiens)
- 3q29 copy number variation syndrome - WP4906 (Homo sapiens)
- 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression - WP3879 (Homo sapiens)
- 4p16.3 copy number variation - WP5365 (Homo sapiens)
- 5q35 copy number variation - WP5380 (Homo sapiens)
- 6q16 copy number variation - WP5400 (Homo sapiens)
- 7-oxo-C and 7-beta-HC pathways - WP5064 (Homo sapiens)
- 7q11.23 copy number variation syndrome - WP4932 (Homo sapiens)
- 7q11.23 distal copy number variation - WP5401 (Homo sapiens)
- 8p23.1 copy number variation syndrome - WP5346 (Homo sapiens)
- 8q11.23 (RB1CC1) copy number variation - WP5412 (Homo sapiens)
- Abnormal calcium handling and its effects on muscle contraction in DMD - WP5343 (Homo sapiens)
- Acetate mediated promotion of metabolic syndrome - WP3650 (Rattus norvegicus)
- Acquired partial lipodystrophy / Barraquer-Simons syndrome - WP5104 (Homo sapiens)
- Acute myeloid leukemia - WP5293 (Homo sapiens)
- Acute viral myocarditis - WP4298 (Homo sapiens)
- Aerobic glycolysis - augmented - WP4628 (Homo sapiens)
- Affected pathways in Duchenne muscular dystrophy - WP5356 (Homo sapiens)
- Allograft rejection - WP2328 (Homo sapiens)
- Alstrom syndrome - WP5202 (Homo sapiens)
- Altered glycosylation of MUC1 in tumor microenvironment - WP4480 (Homo sapiens)
- Alternative pathway of fetal androgen synthesis - WP4524 (Homo sapiens)
- Alzheimer's disease - WP2075 (Mus musculus)
- Alzheimer's disease - WP5124 (Homo sapiens)
- Alzheimer's disease and miRNA effects - WP2059 (Homo sapiens)
- Amino acid metabolism in triple-negative breast cancer cells - WP5213 (Homo sapiens)
- Amino acid transport defects (IEMs) - WP5029 (Homo sapiens)
- Amplification and expansion of oncogenic pathways as metastatic traits - WP3678 (Homo sapiens)
- Amyotrophic lateral sclerosis (ALS) - WP2447 (Homo sapiens)
- Amyotrophic lateral sclerosis (ALS) - WP3243 (Bos taurus)
- Androgen receptor network in prostate cancer - WP2263 (Homo sapiens)
- ApoE and miR-146 in inflammation and atherosclerosis - WP3592 (Mus musculus)
- ApoE and miR-146 in inflammation and atherosclerosis - WP3926 (Homo sapiens)
- Apoptosis-related network due to altered Notch3 in ovarian cancer - WP2864 (Homo sapiens)
- Apoptosis-related network due to altered Notch3 in ovarian cancer - WP3126 (Bos taurus)
- Arrhythmogenic right ventricular cardiomyopathy - WP2118 (Homo sapiens)
- Arrhythmogenic right ventricular cardiomyopathy - WP3195 (Bos taurus)
- Arsenic liver toxicity pathway - WP5228 (Homo sapiens)
- Autophagy in pancreatic ductal adenocarcinoma - WP5331 (Homo sapiens)
- Bardet-Biedl syndrome - WP5234 (Homo sapiens)
- Biomarkers for pyrimidine metabolism disorders - WP4584 (Homo sapiens)
- Biomarkers for urea cycle disorders - WP4583 (Homo sapiens)
- Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine - WP4156 (Homo sapiens)
- Biosynthesis and turnover of 1-deoxy-sphingoid bases - WP5179 (Homo sapiens)
- Biotin metabolism, including IMDs - WP5031 (Homo sapiens)
- Bladder cancer - WP2828 (Homo sapiens)
- Breast cancer pathway - WP4262 (Homo sapiens)
- COVID-19 adverse outcome pathway - WP4891 (Homo sapiens)
- COVID-19 structural coverage map - WP5145 (Homo sapiens)
- COVID-19, thrombosis and anticoagulation - WP4927 (Homo sapiens)
- Calcium mediated T-cell apoptosis involved in inclusion body myositis - WP5142 (Homo sapiens)
- Cancer immunotherapy by CTLA4 blockade - WP4582 (Homo sapiens)
- Cancer immunotherapy by PD-1 blockade - WP4585 (Homo sapiens)
- Cancer pathways - WP5434 (Homo sapiens)
- Cardiac hypertrophic response - WP2795 (Homo sapiens)
- Cardiac hypertrophic response - WP3250 (Bos taurus)
- Cell interactions of the pancreatic cancer microenvironment - WP5284 (Homo sapiens)
- Cerebral organic acidurias, including diseases - WP4519 (Homo sapiens)
- Cholestasis - WP5238 (Homo sapiens)
- Cholesterol biosynthesis with skeletal dysplasias - WP4804 (Homo sapiens)
- Cholesterol metabolism - WP632 (Rattus norvegicus)
- Cholesterol synthesis disorders - WP5193 (Homo sapiens)
- Chromosomal and microsatellite instability in colorectal cancer - WP4216 (Homo sapiens)
- Chronic hyperglycemia impairment of neuron function - WP5283 (Homo sapiens)
- Ciliopathies - WP4803 (Homo sapiens)
- Circulating monocytes and cardiac macrophages in diastolic dysfunction - WP4474 (Mus musculus)
- Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism - WP4523 (Homo sapiens)
- Cohesin complex - Cornelia de Lange syndrome - WP5117 (Homo sapiens)
- Common pathways underlying drug addiction - WP2636 (Homo sapiens)
- Complement system in neuronal development and plasticity - WP5090 (Homo sapiens)
- Congenital generalized lipodystrophy - WP5101 (Homo sapiens)
- Creatine pathway - WP5190 (Homo sapiens)
- Cysteine and methionine catabolism - WP4504 (Homo sapiens)
- DNA adduct formation leading to kidney failure - WP5389 (Homo sapiens)
- DON mycotoxin biosynthesis - WP2258 (Gibberella zeae)
- Degradation pathway of sphingolipids, including diseases - WP4153 (Homo sapiens)
- Dengue-2 interactions with complement and coagulation cascades - WP3896 (Homo sapiens)
- Deregulation of Rab and Rab effector genes in bladder cancer - WP2291 (Homo sapiens)
- Deregulation of Rab and Rab effector genes in bladder cancer - WP3171 (Bos taurus)
- Disorders in ketolysis - WP5195 (Homo sapiens)
- Disorders in ketone body synthesis - WP5175 (Homo sapiens)
- Disorders of bile acid synthesis and biliary transport - WP5176 (Homo sapiens)
- Disorders of folate metabolism and transport - WP4259 (Homo sapiens)
- Disorders of fructose metabolism - WP5178 (Homo sapiens)
- Disorders of galactose metabolism - WP5173 (Homo sapiens)
- Downregulation of ACE2 by SARS-CoV-2 spike protein - WP4799 (Homo sapiens)
- Dravet syndrome - WP5200 (Homo sapiens)
- Dravet syndrome: Scn1a-A1783V point mutation model - WP5298 (Mus musculus)
- EBV LMP1 signaling - WP1224 (Anopheles gambiae)
- EBV LMP1 signaling - WP1243 (Mus musculus)
- EBV LMP1 signaling - WP1278 (Rattus norvegicus)
- EBV LMP1 signaling - WP984 (Bos taurus)
- ERK pathway in Huntington's disease - WP3853 (Homo sapiens)
- Ebstein-Barr virus LMP1 signaling - WP262 (Homo sapiens)
- Effect of progerin on genes involved in progeria - WP4320 (Homo sapiens)
- Endometrial cancer - WP4155 (Homo sapiens)
- Endoplasmic reticulum stress response in coronavirus infection - WP4861 (Homo sapiens)
- Envelope proteins and their potential roles in EDMD physiopathology - WP4535 (Homo sapiens)
- Epithelial to mesenchymal transition in colorectal cancer - WP4239 (Homo sapiens)
- Estradiol regulation in porto-sinusoidal vascular disease - WP5235 (Homo sapiens)
- Ether lipid biosynthesis - WP5275 (Homo sapiens)
- Ethylmalonic encephalopathy - WP5030 (Homo sapiens)
- Extrafollicular and follicular B cell activation by SARS-CoV-2 - WP5218 (Homo sapiens)
- FABP4 in ovarian cancer - WP4400 (Homo sapiens)
- FGFR4 p.G388R signaling pathway - WP5428 (Homo sapiens)
- FOXP3 in COVID-19 - WP5063 (Homo sapiens)
- FTO obesity variant mechanism - WP3407 (Homo sapiens)
- Familial hyperlipidemia type 1 - WP5108 (Homo sapiens)
- Familial hyperlipidemia type 2 - WP5109 (Homo sapiens)
- Familial hyperlipidemia type 3 - WP5110 (Homo sapiens)
- Familial hyperlipidemia type 4 - WP5111 (Homo sapiens)
- Familial hyperlipidemia type 5 - WP5112 (Homo sapiens)
- Familial partial lipodystrophy - WP5102 (Homo sapiens)
- Ferroptosis - WP4313 (Homo sapiens)
- Fluoroacetic acid toxicity - WP4966 (Homo sapiens)
- Fluoropyrimidine activity - WP1601 (Homo sapiens)
- Fluoropyrimidine activity - WP3275 (Bos taurus)
- Folate-alcohol and cancer pathway - WP3120 (Bos taurus)
- Folate-alcohol and cancer pathway hypotheses - WP1589 (Homo sapiens)
- Fragile X syndrome - WP4549 (Homo sapiens)
- Frustrated phagocytosis leading to malignant pleural mesothelioma - WP5091 (Homo sapiens)
- GLP-1 secretion from intestine to portal vein - WP5446 (Homo sapiens)
- GNAQ pathways in port-wine stain - WP5437 (Homo sapiens)
- GPR143 in melanocytes and retinal pigment epithelium cells - WP4941 (Homo sapiens)
- Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases - WP4518 (Homo sapiens)
- Gastric cancer network 1 - WP2361 (Homo sapiens)
- Gastric cancer network 1 - WP3166 (Bos taurus)
- Gastric cancer network 2 - WP2363 (Homo sapiens)
- Gastric cancer network 2 - WP3139 (Bos taurus)
- Genes associated with the development of rheumatoid arthritis - WP5033 (Homo sapiens)
- Genetic alterations of lung cancer - WP1968 (Rattus norvegicus)
- Genetic causes of porto-sinusoidal vascular disease - WP5269 (Homo sapiens)
- Glioblastoma signaling pathways - WP2261 (Homo sapiens)
- Glucose metabolism in triple-negative breast cancer cells - WP5211 (Homo sapiens)
- Glycosylation and related congenital defects - WP4521 (Homo sapiens)
- Glyoxylate metabolism - WP5166 (Homo sapiens)
- HIPK2 in kidney fibrosis - WP4751 (Homo sapiens)
- Head and neck squamous cell carcinoma - WP4674 (Homo sapiens)
- Hemesynthesis defects and porphyrias - WP5169 (Homo sapiens)
- Hepatitis B infection - WP4666 (Homo sapiens)
- Hepatitis C and hepatocellular carcinoma - WP3646 (Homo sapiens)
- Hereditary leiomyomatosis and renal cell carcinoma pathway - WP4206 (Homo sapiens)
- Hijack of ubiquitination by SARS-CoV-2 - WP4860 (Homo sapiens)
- Hippo signaling regulation pathways - WP4540 (Homo sapiens)
- Hippo-Merlin signaling dysregulation - WP4541 (Homo sapiens)
- Histidine metabolism - WP1581 (Mycobacterium tuberculosis)
- Host-pathogen interaction of human coronaviruses - apoptosis - WP4864 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - autophagy - WP4863 (Homo sapiens)
- Hypertrophy model - WP1327 (Danio rerio)
- Hypertrophy model - WP202 (Mus musculus)
- Hypertrophy model - WP442 (Rattus norvegicus)
- Hypertrophy model - WP516 (Homo sapiens)
- Hypertrophy model - WP982 (Bos taurus)
- Hypothesized pathways in pathogenesis of cardiovascular disease - WP3668 (Homo sapiens)
- Hypothetical network for drug addiction - WP1281 (Rattus norvegicus)
- IL1 and megakaryocytes in obesity - WP2865 (Homo sapiens)
- IL1 and megakaryotyces in obesity - WP3160 (Bos taurus)
- Imatinib and chronic myeloid leukemia - WP3640 (Homo sapiens)
- Immune infiltration in pancreatic cancer - WP5285 (Homo sapiens)
- Inclusion body myositis - WP5120 (Homo sapiens)
- Inflammatory bowel disease signaling - WP5198 (Homo sapiens)
- Influence of laminopathies on Wnt signaling - WP4844 (Homo sapiens)
- Influenza A virus infection - WP1438 (Homo sapiens)
- Influenza A virus infection - WP3214 (Bos taurus)
- Initiation of transcription and translation elongation at the HIV-1 LTR - WP3414 (Homo sapiens)
- Integrated cancer pathway - WP1971 (Homo sapiens)
- Integrated cancer pathway - WP3244 (Bos taurus)
- Interactions between LOXL4 and oxidative stress pathway - WP3670 (Homo sapiens)
- Interactions of natural killer cells in pancreatic cancer - WP5092 (Homo sapiens)
- Involvement of δ-secretase in neurodegenerative diseases - WP5372 (Homo sapiens)
- Iron metabolism disorders - WP5172 (Homo sapiens)
- Isoprenoid precursor biosynthesis in Pf apicoplasts - WP2918 (Plasmodium falciparum)
- Joubert syndrome - WP4656 (Homo sapiens)
- KCNQ2-related epilepsies - WP5360 (Homo sapiens)
- Kallmann syndrome - WP5074 (Homo sapiens)
- Kleefstra syndrome - WP5351 (Homo sapiens)
- Krebs cycle disorders - WP4236 (Homo sapiens)
- LDLRAD4 and what we know about it - WP4904 (Homo sapiens)
- Lac-Phe pathway - WP5239 (Homo sapiens)
- Lamin A processing pathway - WP4299 (Homo sapiens)
- Leucine, isoleucine and valine metabolism - WP4686 (Homo sapiens)
- Leukotriene metabolic pathway - WP5171 (Homo sapiens)
- Liver steatosis adverse outcome pathway - WP4010 (Homo sapiens)
- Lung fibrosis - WP3624 (Homo sapiens)
- Lung fibrosis - WP3632 (Mus musculus)
- MAPK pathway in congenital thyroid cancer - WP4928 (Homo sapiens)
- MECP2 and associated Rett syndrome - WP3584 (Homo sapiens)
- MET in type 1 papillary renal cell carcinoma - WP4205 (Homo sapiens)
- MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement - WP4560 (Homo sapiens)
- MFAP5-mediated ovarian cancer cell motility and invasiveness - WP3301 (Homo sapiens)
- MTHFR deficiency - WP4288 (Homo sapiens)
- Macrophage-stimulating protein (MSP) signaling - WP5353 (Homo sapiens)
- Male infertility - WP4673 (Homo sapiens)
- Mecp2 and associated Rett syndrome - WP2910 (Mus musculus)
- Melanoma - WP4685 (Homo sapiens)
- Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia - WP5105 (Homo sapiens)
- Metabolic epileptic disorders - WP5355 (Homo sapiens)
- Metabolic pathway of LDL, HDL and TG, including diseases - WP4522 (Homo sapiens)
- Metabolic reprogramming in colon cancer - WP4290 (Homo sapiens)
- Metabolic reprogramming in pancreatic cancer - WP5220 (Homo sapiens)
- Metastatic brain tumor - WP2249 (Homo sapiens)
- Metastatic brain tumor - WP3259 (Bos taurus)
- Methionine metabolism leading to sulfur amino acids and related disorders - WP4292 (Homo sapiens)
- MicroRNA for targeting cancer growth and vascularization in glioblastoma - WP3593 (Homo sapiens)
- MicroRNAs in cardiomyocyte hypertrophy - WP1544 (Homo sapiens)
- MicroRNAs in cardiomyocyte hypertrophy - WP1560 (Mus musculus)
- Microglia pathogen phagocytosis pathway - WP3626 (Mus musculus)
- Microglia pathogen phagocytosis pathway - WP3937 (Homo sapiens)
- Mitochondrial complex I inhibition leading to chemical-induced Fanconi syndrome - WP4944 (Homo sapiens)
- Mitochondrial complex inhibition leading to liver injury - WP5034 (Homo sapiens)
- Mitochondrial fatty acid oxidation disorders - WP5123 (Homo sapiens)
- Mitochondrial immune response to SARS-CoV-2 - WP5038 (Homo sapiens)
- Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors - WP4397 (Homo sapiens)
- Modified nucleosides derived from tRNA as urinary cancer markers - WP4485 (Homo sapiens)
- Molybdenum cofactor (Moco) biosynthesis - WP4507 (Homo sapiens)
- Multiple epiphyseal dysplasia and pseudoachondroplasia genes - WP4789 (Homo sapiens)
- NF1 copy number variation syndrome - WP5366 (Homo sapiens)
- NIPBL role in DNA damage - Cornelia de Lange syndrome - WP5119 (Homo sapiens)
- NPHP1 deletion syndrome - WP5399 (Homo sapiens)
- NRP1-triggered signaling pathways in pancreatic cancer - WP5144 (Homo sapiens)
- NRXN1 deletion syndrome - WP5398 (Homo sapiens)
- Nephrotic syndrome - WP4758 (Homo sapiens)
- Nephrotoxcicity adverse outcome pathway - WP5229 (Homo sapiens)
- Netrin-UNC5B signaling pathway - WP4747 (Homo sapiens)
- Network map of SARS-CoV-2 signaling pathway - WP5115 (Homo sapiens)
- Neural crest cell migration in cancer - WP4565 (Homo sapiens)
- Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway - WP4577 (Homo sapiens)
- Neuroinflammation and glutamatergic signaling - WP5083 (Homo sapiens)
- Neurotransmitter disorders - WP4220 (Homo sapiens)
- Nitric oxide metabolism in cystic fibrosis - WP4947 (Homo sapiens)
- Non-small cell lung cancer - WP4255 (Homo sapiens)
- Nonalcoholic fatty liver disease - WP4396 (Homo sapiens)
- Osteoblast differentiation and related diseases - WP4787 (Homo sapiens)
- Ovarian infertility - WP273 (Mus musculus)
- Ovarian infertility - WP34 (Homo sapiens)
- Overlap between signal transduction pathways contributing to LMNA laminopathies - WP4879 (Homo sapiens)
- Oxysterols derived from cholesterol - WP4545 (Homo sapiens)
- PAFAH1B1 copy number variation - WP5409 (Homo sapiens)
- PDGFR-beta pathway - WP3972 (Homo sapiens)
- PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer - WP3844 (Homo sapiens)
- PI3K-Akt signaling pathway - WP4172 (Homo sapiens)
- Pancreatic adenocarcinoma pathway - WP4263 (Homo sapiens)
- Pancreatic cancer subtypes - WP5390 (Homo sapiens)
- Parkinson's disease - WP3638 (Mus musculus)
- Parkinson's disease pathway - WP2371 (Homo sapiens)
- Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex - WP4884 (Homo sapiens)
- Pathogenic Escherichia coli infection - WP2272 (Homo sapiens)
- Pathogenic Escherichia coli infection - WP3157 (Bos taurus)
- Pathophysiological roles of DUX4 in FSHD1 - WP5342 (Homo sapiens)
- Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins - WP4936 (Homo sapiens)
- Physico-chemical features and toxicity-associated pathways - WP3680 (Homo sapiens)
- Physiological and pathological hypertrophy of the heart - WP1528 (Homo sapiens)
- Pilocytic astrocytoma - WP2253 (Homo sapiens)
- Pilocytic astrocytoma - WP3122 (Bos taurus)
- Pleural mesothelioma - WP5087 (Homo sapiens)
- Polycystic kidney disease pathway - WP2571 (Homo sapiens)
- Polyol pathway - WP690 (Homo sapiens)
- Prader-Willi and Angelman syndrome - WP3998 (Homo sapiens)
- Primary focal segmental glomerulosclerosis (FSGS) - WP2572 (Homo sapiens)
- Primary focal segmental glomerulosclerosis (FSGS) - WP2573 (Mus musculus)
- Primary focal segmental glomerulosclerosis (FSGS) - WP3233 (Bos taurus)
- Prion disease pathway - WP3995 (Homo sapiens)
- Pro-survival signaling of neuroprotectin D1 - WP5182 (Homo sapiens)
- Progeria-associated lipodystrophy - WP5103 (Homo sapiens)
- Proline and hydroxyproline pathways - WP5026 (Homo sapiens)
- Protein alkylation leading to liver fibrosis - WP3980 (Homo sapiens)
- Purine metabolism and related disorders - WP4224 (Homo sapiens)
- Pyrimidine metabolism and related diseases - WP4225 (Homo sapiens)
- RAC1/PAK1/p38/MMP2 pathway - WP3303 (Homo sapiens)
- RAS and bradykinin pathways in COVID-19 - WP4969 (Homo sapiens)
- RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis - WP3873 (Homo sapiens)
- ROS in COVID-19 endothelial dysfunction - WP5258 (Homo sapiens)
- Regulation of cardiac hypertrophy by miR-208 - WP1526 (Mus musculus)
- Retinoblastoma gene in cancer - WP2446 (Homo sapiens)
- Retinoblastoma gene in cancer - WP3206 (Bos taurus)
- Rett syndrome - WP4312 (Homo sapiens)
- Roles of ceramides in development of insulin resistance - WP5181 (Homo sapiens)
- Rubinstein-Taybi syndrome 1 - WP5367 (Homo sapiens)
- SARS-CoV-2 altering angiogenesis via NRP1 - WP5065 (Homo sapiens)
- SARS-CoV-2 and COVID-19 pathway - WP4846 (Homo sapiens)
- SARS-CoV-2 innate immunity evasion and cell-specific immune response - WP5039 (Homo sapiens)
- SARS-CoV-2 replication organelle formation - WP5156 (Homo sapiens)
- SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome - WP5118 (Homo sapiens)
- STING pathway in Kawasaki-like disease and COVID-19 - WP4961 (Homo sapiens)
- Salmonella virulence regulatory network - WP5070 (Escherichia coli)
- Serotonin and anxiety - WP2132 (Rattus norvegicus)
- Serotonin and anxiety-related events - WP2140 (Mus musculus)
- Serotonin and anxiety-related events - WP3944 (Homo sapiens)
- Sildenafil treatment - WP5294 (Homo sapiens)
- Small cell lung cancer - WP4658 (Homo sapiens)
- Smith-Magenis and Potocki-Lupski syndrome copy number variation - WP5381 (Homo sapiens)
- Spinal cord injury - WP2431 (Homo sapiens)
- Spinal cord injury - WP2432 (Mus musculus)
- Spinal cord injury - WP2433 (Rattus norvegicus)
- Spinal cord injury - WP3186 (Bos taurus)
- Statin pathway - WP1 (Mus musculus)
- Sudden infant death syndrome (SIDS) susceptibility pathways - WP706 (Homo sapiens)
- T cell modulation in pancreatic cancer - WP5078 (Homo sapiens)
- T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection - WP3863 (Homo sapiens)
- TAR syndrome - WP5362 (Homo sapiens)
- TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) - WP2453 (Homo sapiens)
- TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) - WP3149 (Bos taurus)
- TCA cycle nutrient use and invasiveness of ovarian cancer - WP2868 (Homo sapiens)
- TCA cycle nutrient use and invasiveness of ovarian cancer - WP3252 (Bos taurus)
- TLR4 signaling and tolerance - WP3851 (Homo sapiens)
- TYROBP causal network in microglia - WP3945 (Homo sapiens)
- Tamoxifen metabolism - WP3264 (Bos taurus)
- Tamoxifen metabolism - WP691 (Homo sapiens)
- Thyroid hormones production and peripheral downstream signaling effects - WP4746 (Homo sapiens)
- Toll-like receptor signaling related to MyD88 - WP3858 (Homo sapiens)
- Transcription factors regulate miRNAs related to cardiac hypertrophy - WP1559 (Homo sapiens)
- Translation inhibitors in chronically activated PDGFRA cells - WP4566 (Homo sapiens)
- Tumor suppressor activity of SMARCB1 - WP4204 (Homo sapiens)
- Type 2 papillary renal cell carcinoma - WP4241 (Homo sapiens)
- Type I collagen synthesis in the context of osteogenesis imperfecta - WP4786 (Homo sapiens)
- Type II diabetes mellitus - WP1584 (Homo sapiens)
- Type II diabetes mellitus - WP3117 (Bos taurus)
- Tyrobp causal network in microglia - WP3625 (Mus musculus)
- Tyrosine metabolism and related disorders - WP4506 (Homo sapiens)
- Ulcerative colitis signaling - WP5174 (Homo sapiens)
- Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer - WP4284 (Homo sapiens)
- Urea cycle and associated pathways - WP4595 (Homo sapiens)
- Urea cycle and related diseases - WP4571 (Homo sapiens)
- Vitamin B12 disorders - WP4271 (Homo sapiens)
- Vitamin B6-dependent and responsive disorders - WP4228 (Homo sapiens)
- Vitamin D in inflammatory diseases - WP4482 (Homo sapiens)
- Wnt signaling in kidney disease - WP3857 (Mus musculus)
- Wnt signaling in kidney disease - WP4150 (Homo sapiens)
- lncRNA in canonical Wnt signaling and colorectal cancer - WP4258 (Homo sapiens)
- lncRNA-mediated mechanisms of therapeutic resistance - WP3672 (Homo sapiens)
- mRNA vaccine activation of dendritic cell and induction of IFN-1 - WP5187 (Homo sapiens)
- miR-509-3p alteration of YAP1/ECM axis - WP3967 (Homo sapiens)
- miRNA regulation of p53 pathway in prostate cancer - WP3982 (Homo sapiens)
- miRNA regulation of prostate cancer signaling pathways - WP3981 (Homo sapiens)
- mir-193a and MVP in colon cancer metastasis - WP3979 (Mus musculus)
- ncRNAs involved in STAT3 signaling in hepatocellular carcinoma - WP4337 (Homo sapiens)
- ncRNAs involved in Wnt signaling in hepatocellular carcinoma - WP4336 (Homo sapiens)